We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

AKBNK:BISTAkbank T.A.S. Analysis

Data as of 2026-03-11 - not real-time

TRY 75.75

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Akbank trades at a **trailing P/E of 6.9**, well below the industry average of 17.3, and the consensus target price of ~99.8 TRY implies a **31% upside** from the current 75.75 TRY level. The bank posted **63% revenue growth**, a solid **operating margin of 47.6%**, and a **ROE of 20.8%**, while maintaining a **dividend yield of 2.86%** with an ultra‑low payout ratio of 11%, indicating sustainable income. Technically, the stock sits above its 200‑day SMA (68.3) but below the 20‑day SMA (84.9), the **RSI of 38.6** hints at near‑oversold conditions, yet the **MACD is bearish** (line –2.10 vs signal –0.29) and volume is trending down, suggesting short‑term pressure.
The upcoming issuance of a **USD‑denominated perpetual bond** will add to the capital base but also increase leverage, while the bank’s **beta is exceptionally low** (≈0.09) and **30‑day volatility is high** (55%). Despite a **max drawdown of 35%** and a sizable debt load, the low payout, strong profitability, and strong analyst consensus (**strong‑buy**) support a **medium‑ to long‑term buy** stance, tempered by macro‑economic and currency headwinds in Turkey.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near support at 69.3 TRY
  • RSI approaching oversold territory
  • Bearish MACD momentum with decreasing volume

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant upside to target price (~31%)
  • Undervalued valuation relative to peers
  • Strong earnings growth and sustainable dividend

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Robust ROE and operating margins
  • Low payout ratio ensuring dividend sustainability
  • Long‑term growth prospects despite macro‑economic risks

Key Metrics & Analysis

Financial Health

Revenue Growth63.20%
Profit Margin30.09%
P/E Ratio6.9
ROE20.79%
ROA1.84%
P/B Ratio1.3
Op. Cash FlowTRY-572498509824
Industry P/E17.3

Technical Analysis

TrendBullish
RSI38.6
SupportTRY 69.30
ResistanceTRY 93.50
MA 20TRY 84.95
MA 50TRY 81.67
MA 200TRY 68.34
MACDBearish
VolumeDecreasing
Fear & Greed Index76.04

Valuation

Target PriceTRY 99.78
Upside/Downside31.72%
GradeUndervalued
TypeBlend
Dividend Yield2.86%

Risk Assessment

Beta0.09
Volatility55.60%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.